Guo Y X, Wang D C, Liu X J, Wang E B, An J G, Peng X, Guo C B
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.
Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 May 9;56(5):452-457. doi: 10.3760/cma.j.cn112144-20210104-00003.
To evaluate the preliminary clinical effect of flap-raising and cortical-perforation based extraction method in patients with potential risk of medication-related osteonecrosis of the jaw (MRONJ). Eighteen patients, who needed teeth extraction in the Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology from February 2016 to November 2020, with a history of using anti-resorption/anti-angiogenesis medication were included in this retrospective study. According to the characteristics of the patient's medication history, patients were stratified into three categories, low-dose anti-resorption drug group, high-dose anti-resorption drug group, and high-dose anti-resorption combined with anti-angiogenesis targeted drug group. There were 15 females and 3 males, the average age was 62.4 years (range from 27 to 87 years) old. A total of 31 teeth were indicated for extraction due to chronic infection. The flap-raising and cortical-perforation techniques were used to extract the affected teeth, and the patients were followed up closely. By observing the healing status and swelling degree of the mucosa of tooth extraction sites, whether there was a fistula, pus and bone exposure of jaw bone,the healing of the tooth extraction sites were evaluated. Among the 18 patients, there were 9 cases of osteoporosis and 9 cases of malignant tumors. Classified by medication-using history, 10 cases were treated with low-dose anti-resorption drugs, 5 cases were high-dose anti-resorption drugs, and 3 cases were high-dose anti-resorption drugs combined with anti-angiogenesis drugs. A total of 31 teeth of the patients were extracted by flap-raising and cortical-perforation based extraction method. Thirteen patients completed treatment underwent local anesthesia and five cases were performed under general anesthesia. The shortest follow-up period was 3 months with an average of 13.2 months. Seventeen patients recovered well after the tooth extraction. One patient had the mandible exposed at one extraction site one month after the surgery, resulting in MRONJ. In patients with potential risks of MRONJ, the application of flap-raising and cortical-perforation based teeth extraction method could safely and effectively alleviate the dental inflammation in the oral cavity.
评估翻瓣及皮质骨穿孔拔牙法在有药物相关性颌骨坏死(MRONJ)潜在风险患者中的初步临床效果。纳入2016年2月至2020年11月在北京大学口腔医学院口腔颌面外科需要拔牙且有使用抗骨吸收/抗血管生成药物史的18例患者进行这项回顾性研究。根据患者用药史特点,将患者分为低剂量抗骨吸收药物组、高剂量抗骨吸收药物组和高剂量抗骨吸收联合抗血管生成靶向药物组。其中女性15例,男性3例,平均年龄62.4岁(27~87岁)。因慢性感染共需拔除31颗牙齿。采用翻瓣及皮质骨穿孔技术拔除患牙,并对患者进行密切随访。通过观察拔牙创黏膜愈合情况及肿胀程度、有无瘘管、有无脓性分泌物及颌骨骨质暴露情况,评估拔牙创愈合情况。18例患者中,骨质疏松9例,恶性肿瘤9例。按用药史分类,低剂量抗骨吸收药物治疗10例,高剂量抗骨吸收药物治疗5例,高剂量抗骨吸收联合抗血管生成药物治疗3例。采用翻瓣及皮质骨穿孔拔牙法共拔除患者31颗牙齿。13例患者在局部麻醉下完成治疗,5例在全身麻醉下进行。最短随访时间3个月,平均13.2个月。17例患者拔牙后恢复良好。1例患者术后1个月在1个拔牙创处出现下颌骨暴露,导致MRONJ。对于有MRONJ潜在风险的患者,应用翻瓣及皮质骨穿孔拔牙法可安全有效地缓解口腔内的牙齿炎症。